News
After Two Cancer Diagnoses, Young Cancer Survivor Looks Ahead with Confidence
... Here goes the content ...
Miller School researchers found that higher p-tau181 blood levels were linked to poorer memory performance six years later in older adults. A TMEM106B variant is linked to TDP-43 pathology in Alzheimer’s disease, offering clues to why cognitive decline differs among patients. Sylvester researchers are studying whether routine nutrition and immune markers can help predict symptom burden during and after chemotherapy. More than 200 parents met Miller School leaders and learned how the school will support the medical students in its Class of 2030.
Blood Biomarker May Signal Memory Vulnerability Years Before Cognitive Changes
TMEM106B Variant Linked to TDP-43 Pathology in Alzheimer’s Disease
Can Routine Lab Data Predict Chemotherapy Side Effects?
MedCanes Family Reception Welcomes Parents of the Class of 2030
